HealthCare Global Enterprises Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, to the National Stock Exchange of India Limited and BSE Limited. The filing covers consolidated operations across its network of cancer care centres and hospitals in India and Kenya.

The report discloses that the company’s turnover for FY26 stood at ₹25,384.29 million, while its net worth was reported at ₹13,319.70 million. These figures make the company eligible for Corporate Social Responsibility (CSR) obligations under Section 135 of the Companies Act, 2013. International business revenue contributed 2.13% to the total turnover.

What the Numbers Show

A notable divergence exists between the company’s energy consumption trends and its emission intensity metrics. While total energy consumption decreased from 194,224.10 GJ in FY25 to 170,621.49 GJ in FY26, the energy intensity per rupee of turnover also fell significantly from 0.000008756185 to 0.0000067215. This suggests improved operational efficiency relative to revenue generation, despite a larger physical footprint or patient volume potentially driving absolute usage elsewhere. Additionally, Scope 1 emissions rose sharply from 468.77 metric tonnes of CO₂ equivalent to 1,311.97 metric tonnes, even as Scope 2 emissions declined from 34,415.84 to 29,172.37 metric tonnes. This shift warrants attention regarding direct operational emissions versus purchased electricity impacts.

Environmental Disclosures

The company reported total water withdrawal of 432,986.22 kilolitres, a slight decrease from 443,640 kilolitres in the previous year. Water intensity per rupee of turnover dropped from 0.0000200005771 to 0.0000170573. Total waste generated increased to 578.51 metric tonnes from 536.774 metric tonnes. Bio-medical waste constituted the largest share at 454.92 metric tonnes. The company does not have a Zero Liquid Discharge mechanism in place.

Employee Welfare and Governance

As of March 31, 2026, the company employed 8,355 individuals, comprising 6,759 permanent and 1,596 non-permanent staff. Female employees accounted for 48% of the total workforce. The turnover rate for permanent employees was 25% in FY26, down from 31% in FY25. The board of directors includes three women, representing 30% of the total membership.

The company recorded eight complaints related to sexual harassment under the POSH Act in FY26, identical to the previous year. One case remains pending resolution. No complaints were received regarding discrimination, child labour, or forced labour. All permanent employees are covered by health and accident insurance.

HealthCare Global Enterprises Limited has released the transcript of its earnings call for Q1 FY27, providing investors and analysts with management's detailed commentary on the company's financial performance and strategic direction for the quarter ended June 30, 2026. The earnings call was conducted on August 07, 2026, following an earlier intimation dated July 27, 2026, and covered both standalone and consolidated figures.

Revenue and Margin Guidance

Management maintained a mid-teens revenue growth outlook, driven by contributions from both existing and new centers. The company has set clear EBITDA margin targets, aiming for 21-22% within the next two years and 25% within the next four to five years. The following table summarizes the key guidance parameters shared during the concall:

Margin improvement is expected to be driven by a better payor mix, increased clinical complexity, reduced losses from new hospitals, and operating leverage as centers mature. Investment in clinical technology is also cited as a key enabler of the long-term margin trajectory.

Bed Expansion Plans

HealthCare Global Enterprises outlined a structured bed expansion roadmap spanning FY27 through FY30. Approximately 60% of the planned additions are from brownfield projects, which are expected to enable faster execution and lower capital expenditure compared to greenfield developments. The planned expansion is detailed below:

North Bangalore Hospital Update

Management provided a specific update on the North Bangalore hospital, which is expected to achieve monthly break-even during the current year. The facility is projected to reach optimal utilization of 60-65% within three to four years of operation. Losses from this center, which peaked in Q1, are projected to decrease going forward, contributing positively to the overall margin improvement narrative shared by management.

Regulatory Compliance and Investor Access

The disclosure was made in accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was submitted to the Compliance Departments of both the National Stock Exchange of India Limited and BSE Limited. The full audio recording of the earnings call is available on the company's official investor relations website, enabling stakeholders to access management's commentary on quarterly performance, payor mix trends, clinical complexity, and capital expenditure plans directly.